115 related articles for article (PubMed ID: 30498313)
1. Correlation of expression of aberrant immunophenotypic markers in T-ALL with its morphology: A pilot study.
Garg N; Kotru M; Kumar D; Pathak R; Sikka M
J Lab Physicians; 2018; 10(4):410-413. PubMed ID: 30498313
[TBL] [Abstract][Full Text] [Related]
2. Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias.
Suggs JL; Cruse JM; Lewis RE
Exp Mol Pathol; 2007 Dec; 83(3):471-3. PubMed ID: 17963747
[TBL] [Abstract][Full Text] [Related]
3. T-cell acute lymphoblastic leukemia with co-expression of CD56, CD34, CD117 and CD33: A case with poor prognosis.
Eren R; Aslan C; Yokuş O; Doğu MH; Suyani E
Mol Clin Oncol; 2016 Aug; 5(2):331-332. PubMed ID: 27446573
[TBL] [Abstract][Full Text] [Related]
4. Characterization of immunophenotypic aberrancies in adult and childhood acute lymphoblastic leukemia: A study from Northern India.
Sharma M; Sachdeva MU; Varma N; Varma S; Marwaha RK
J Cancer Res Ther; 2016; 12(2):620-6. PubMed ID: 27461621
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias.
Lai R; Juco J; Lee SF; Nahirniak S; Etches WS
Am J Clin Pathol; 2000 Jun; 113(6):823-30. PubMed ID: 10874883
[TBL] [Abstract][Full Text] [Related]
6. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.
Sidhom I; Shaaban K; Soliman S; Ezzat S; El-Anwar W; Hamdy N; Yassin D; Salem S; Hassanein H; Mansour MT
J Egypt Natl Canc Inst; 2008 Jun; 20(2):111-20. PubMed ID: 20029466
[TBL] [Abstract][Full Text] [Related]
8. The immunophenotype of adult T acute lymphoblastic leukemia in Morocco.
Lahjouji A; Bachir F; Bennani S; Quessar A; Amzazi S
Exp Oncol; 2015 Mar; 37(1):64-9. PubMed ID: 25804235
[TBL] [Abstract][Full Text] [Related]
9. [Application of flow cytometry in the differential diagnosis of lymphoma/leukemia with aberrant antigen expression].
Xia CQ; Chen SL; Qi M; Xu XF
Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):532-5. PubMed ID: 15634450
[TBL] [Abstract][Full Text] [Related]
10. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
Liu YL; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
[TBL] [Abstract][Full Text] [Related]
11. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
12. Defining an Optimal Number of Immunophenotypic Markers for Lineage Assignment of Acute Leukemias Based on the EGIL Scoring System.
Lee ST; Kim HJ; Kim SH
Korean J Lab Med; 2006 Dec; 26(6):393-9. PubMed ID: 18156757
[TBL] [Abstract][Full Text] [Related]
13. CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemia.
Hoehn D; Medeiros LJ; Chen SS; Tian T; Jorgensen JL; Ahmed Y; Lin P
Am J Clin Pathol; 2012 Feb; 137(2):213-9. PubMed ID: 22261446
[TBL] [Abstract][Full Text] [Related]
14. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
15. Distribution of subtypes and immunophenotypic characterization of 1379 cases of paediatric acute leukaemia.
Jamal S; Meraj F; Mansoor N; Parveen S; Shaikh A; Jabbar N
Pak J Med Sci; 2021; 37(3):805-811. PubMed ID: 34104169
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
17. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759
[TBL] [Abstract][Full Text] [Related]
18. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of immunophenotype of B-lineage acute lymphoblastic leukemia cells by 4-color flow cytometry].
Wang H; Liu YR; Chen SS; Chang Y; Qin YZ; Li JL; Fu JY; Ruan GR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):137-41. PubMed ID: 12744734
[TBL] [Abstract][Full Text] [Related]
20. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
Kozlov I; Beason K; Yu C; Hughson M
Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]